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Tuning the hydrophobic cores of self-immolative polyglyoxylate 
assemblies  
Bo Fan,a Rebecca E. Yardley,b John F. Trant,b Aneta Borecki,b Elizabeth R. Gilliesab* 
Polyglyoxylates are a recently-introduced class of self-immolative polymers, that depolymerize to small molecules upon the 
cleavage of a stimuli-responsive end-cap from the polymer terminus. The incorporation of different pendant ester groups 
or other aldehyde monomers offers the potential to tune the polymer properties, but this remains largely unexplored. With 
the goal of tuning the self-assembly and drug-loading properties of polyglyoxylate block copolymers, we explored the 
polymerization and copolymerization of n-butyl glyoxylate, L-menthyl glyoxylate, and chloral with ethyl glyoxylate to form 
UV light-responsive polyglyoxylates. The resulting polymers were coupled to poly(ethylene glycol) to afford amphiphilic 
block copolymers. Self-assembly of the different copolymers was studied and although each system formed solid particles, 
the cores of the assemblies differed in their stability, hydrophobicity, and their ability to load the hydrophobic drug 
celecoxib. All systems depolymerized and released the drug in response to UV light. The toxicity profiles for the assemblies 
were also evaluated using MDA-MB-231 cells. Overall, this work demonstrates that the properties of polyglyoxylates and 
their assemblies can be readily tuned through the incorporation of new monomers, thereby providing a promising platform 
for drug delivery and other applications. 
 
Introduction 
Biodegradable polymers such as poly(lactic acid), 
poly(caprolactone) and poly(glycolic acid) have been 
extensively studied over the past few decades as replacements 
for traditional non-degradable polymers.1-3 In particular, these 
biodegradable polymers are of significant interest as biomedical 
materials such as sutures,4 tissue engineering scaffolds,2 and 
drug delivery vehicles.5 Polyester nanoparticles have emerged 
as promising materials for the delivery of drugs, where they can 
address limitations of drugs such as poor water solubility, low 
stability, and toxic side effects.6, 7 Thus far, several examples of 
polyester-based nanoparticles loaded with anti-cancer drugs 
have been approved for clinical trials in different countries, and 
GenexolTM-PM, a formulation based on PEG-b-poly(D,L-lactic 
acid) with paclitaxel incorporated, has been approved by the 
FDA.6, 8 However, the degradation of polyesters and the release 
of drugs from these systems are challenging to control and 
cannot be precisely controlled or “turned on” when needed.9,10   
Stimuli-responsive polymers that can respond to external 
stimuli through degradation have been proposed as potential 
alternatives to polyesters.11,12 Systems responsive to changes in 
pH13,14 or temperature,15 oxidation,16 reduction,17 light18 and 
other stimuli have been explored and promising results have 
been achieved, particularly in drug delivery. Over the past 
decade, a new class of stimuli-responsive polymers, often 
referred to as “self-immolative polymers” (SIPs) has emerged.19-
21 SIPs are composed of a polymer backbone with stimuli-
responsive end-caps at one or both termini. Cleavage of the 
end-cap results in reaction cascade leading to complete end-to-
end depolymerization. One advantage of SIPs is their ability to 
amplify signals, as one stimulus event can generate hundreds of 
small molecules. This has led to proof-of-concept applications 
of SIPs in molecular sensors,22 microcapsules,23-25 point-of-care 
assay devices,26 and drug delivery.27,28 In addition, while 
traditional stimuli-responsive polymers require a substantial 
polymer redesign to change the stimulus to which the system 
responds, end-caps responsive to different stimuli can easily be 
introduced to SIPs while retaining the same backbone.29 This 
makes each backbone relatively versatile. Backbones including 
polycarbamates,22 polycarbonates,30,31 poly(benzyl ether)s32,33 
and polyacetals34,35 have been reported and end-caps 
responsive to stimuli including light,27,34,36,37 redox agents,27,29,38 
enzymes,22,39 and changes in pH24,29 or temperature40,41 have 
been incorporated.  
In our previous work, we demonstrated that self-immolative 
poly(ethyl glyoxylate) (PEtG) could be coupled with hydrophilic 
poly(ethylene glycol) (PEG) via stimuli-responsive linker end-
caps to form amphiphilic block copolymers.28 These copolymers 
were self-assembled into nanoparticles that could load and 
release drugs in response to low concentrations of stimuli. 
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However, we found that the drug loading capabilities of PEtG-
based particles were somewhat limited, ranging from 6.6 to 13 
wt% depending on the drug. This limited drug loading was 
attributed to the relatively low hydrophobicity of PEtG. We 
hypothesized that it might be possible to tune the properties of 
the polyglyoxylate cores by incorporation of more hydrophobic 
glyoxylate monomers. Therefore, in this work we report the 
homopolymerization and copolymerization of n-butyl 
glyoxylate, L-menthyl glyoxylate, and chloral with ethyl 
glyoxylate to obtain new polyglyoxylates. These polyglyoxylates 
were incorporated into block copolymers and self-assembled to 
form particles. It is shown that these new assemblies have 
significantly improved drug loading capabilities, yet retain the 
important ability of SIPs to degrade and release drugs in 
response to external stimuli.  
Experimental section 
General materials 
 n-Butyl glyoxylate,34 the linker end-cap,34 PEG-N3 (2 and 5 
kg/mol),42 and PEtG-PEG200028 (same batch used here) were 
synthesized as previously reported. Ethyl glyoxylate in toluene 
solution (50% w/w) and L-menthol were obtained from Alfa 
Aesar. Fumaryl chloride, dimethyl sulfide, chloral hydrate, and 
P2O5 were purchased from Sigma-Aldrich. Celecoxib was 
purchased from Ontario Chemicals Inc. Penstrep, fetal bovine 
serum (FBS), trypsin-EDTA (0.25%) and Dulbecco’s modified 
Eagle medium (DMEM) with 4.5 g/L D-glucose and 110 mg/L 
sodium pyruvate were obtained from Gibco. NEt3 and CH2Cl2 
were distilled from CaH2 before use. Anhydrous DMF was 
obtained from a solvent purification system using Al2O3 
columns. Ethyl glyoxylate was purified as previously reported.40 
All the other chemicals were reagent grade and used without 
further purification unless otherwise noted.  
General methods  
1H NMR spectra were obtained at 400 MHz or 600 MHz on 
Varian Inova instruments. NMR chemical shifts (δ) are reported 
in ppm and were calibrated against residual solvent signals of 
CDCl3 (δ 7.27). Fourier transform infrared (FTIR) spectra were 
obtained in attenuated total reflectance mode using a 
PerkinElmer UATR Spectrum Two with films drop cast from 
CH2Cl2 on diamond. High-resolution mass spectrometry (HRMS) 
was performed with either a Thermo Scientific DFS (Double 
Focus Sector) mass spectrometer, using a reversed Nier Johnson 
geometry for electron impact (EI) ionization, or a Bruker 
microOTOF 11 for electrospray ionization (ESI). Size exclusion 
chromatography (SEC) was performed using a Viscotek GPC Max 
VE2001 solvent module equipped with a Viscotek VE3580 RI 
detector, two Agilent Polypore (300 ´ 7.5mm) columns 
connected in series and a Polypore guard column (50 ´ 7.5mm). 
Samples were dissolved in THF (glass distilled grade) at 5 
mg/mL, filtered through 0.22 µm syringe filters, and injected 
using a 100 µL loop. The THF eluent was filtered and eluted at 1 
mL/min. A calibration curve was obtained from poly(methyl 
methacrylate (PMMA) standards with molar masses of 1540-
1,126,000 g/mol. Differential scanning calorimetry (DSC) was 
performed using a Q2000 from TA Instruments (New Castle, 
DE). The heating/cooling rate was 10 °C /min from -60 to +100 
°C or -60 to +150 °C. Glass transition temperatures (Tg) were 
obtained from the second heating cycle. Thermogravimetric 
analyses (TGA) were performed on a TGA Q50 from TA 
Instruments. The heating rate was 10 °C/min between 30-500 
°C under N2. Dialyses were performed using Spectra/Por 
regenerated cellulose membranes with molecular weight cut-
offs (MWCO) of either 2, 3.5, 6-8, 50 kg/mol. The hydrodynamic 
diameters of the polymer assemblies were measured by 
dynamic light scattering (DLS) using a Zetasizer Nano Series ZS 
instrument from Malvern Instruments with laser wavelength at 
633 nm, at 25 °C in a 1 cm path length glass cuvette at a 
concentration of 1.0 mg/mL. TEM imaging was performed using 
a Phillips CM10 microscope operating at an acceleration voltage 
of 80 kV. 3 μL of micelle suspension (0.1 mg/mL) was placed 
onto a copper grid. The resulting sample was air-dried overnight 
before imaging. At least 40 particles were measured to obtain 
the mean particle diameters. Ultraviolet light irradiation was 
performed using an ACE Glass photochemistry cabinet 
containing a mercury light source (450 W bulb, 1.5 mW/cm2 of 
UVA radiation and 0.06 mW/cm2 of UVB radiation).  
Synthesis of poly[(ethyl glyoxylate)-co-chloral] (PEtGC) and 
representative polymer synthesis procedure (additional 
procedures in the ESI)  
First, chloral hydrate was converted to chloral. Chloral hydrate 
(10.0 g, 60 mmol, 1 equiv.) and P2O5 (8.5 g, 30 mmol, 0.5 equiv.) 
were mixed together under an N2 atmosphere in a flamed-dried 
flask equipped with a magnetic stir bar. The flask was then 
heated in an oil bath, and the chloral hydrate started to melt 
when temperature reached 90 °C, resulting in its dehydration 
by P2O5. The resulting pale-yellow liquid (5.6 g, 64%) was 
collected using a short path distillation head when the 
temperature was ~ 110 °C at ambient pressure. The identity of 
the product was confirmed by 1H NMR spectroscopy in CDCl3 (δ 
= 9.05, s, 1H).43 The purified chloral was then used for 
polymerization immediately. For the copolymer synthesis, 
purified ethyl glyoxylate (5.0 mL, 50.0 mmol, 1.0 equiv.) and 
chloral (1.0 mL, 9.5 mmol, 0.19 equiv.) were dissolved in CH2Cl2 
(10.0 mL) and Et3N (3.5 µL, 25 µmol, 0.0005 equiv.) was added. 
The solution was stirred for 1 h at -20 °C. Linker end-cap34 (0.30 
g, 1.0 mmol, 0.02 equiv.) suspended in CH2Cl2 (10.0 mL) and 
NEt3 (0.2 mL, 1.5 mmol, 0.03 equiv.) was added at -20 °C to end-
cap the polymer. The solution was gradually warmed to room 
temperature and then stirred for 16 h. The solution was then 
precipitated into methanol and the solvent was decanted. The 
resulting residue was dried in vacuo to provide a white sticky 
polymer (2.1 g, 35%). 1H NMR (400 MHz, CDCl3): δ 5.48-6.26 (m, 
1.0 H), 4.15-4.31 (m, 1.9 H), 1.23-1.36 (m, 2.9 H). FTIR: 3058, 
2986, 1756 cm-1. SEC: Mn = 37 kg/mol, Mw = 55 kg/mol, Đ = 1.5.  
Synthesis of PEtGC-PEG2000 and representative procedure for the 
synthesis of an amphiphilic block copolymer  
2 kg/mol PEG-N3 (97 mg, 48.6 μmol, 6.0 equiv.) and PEtGC (300 
mg, 8.1 μmol, 1.0 equiv.) were dissolved in DMF (5.0 mL) and 
then placed under an Ar atmosphere. CuSO4 (4.0 mg, 28 μmol, 
3.5 equiv.) and sodium ascorbate (5.0 mg, 28 μmol, 3.5 equiv.) 
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were then added and the mixture was stirred at 40 °C for 16 h. 
The reaction mixture was then transferred into a regenerated 
cellulose membrane (50 kg/mol MWCO) and dialyzed against 
deionized water for 16 h (1 L, 2 solvent changes) to remove DMF 
and most free PEG. The dialyzed material was then lyophilized, 
washed 3 times with water to further remove free PEG, and 
then dried to afford 300 mg (90% yield) of the product as a 
white rubbery solid. 1H NMR (600 MHz, CDCl3): δ 5.42-5.97 (m, 
340 H), 4.10-4.30 (m, 697 H), 3.62 (s, 364 H), 3.36 (s, 5 H), 1.20-
1.34 (m, 1054 H). FTIR: 3058, 2986, 2944, 2874, 1751, 1755 cm-
1. SEC: Mn = 41 kg/mol, Mw = 53 kg/mol, Đ = 1.3.  
Polymer self-assembly 
10 mg of block copolymer was dissolved in 1.0 mL of DMSO with 
stirring overnight. 0.1 mL of the resulting solution was then 
rapidly injected into 0.9 mL of rapidly stirring deionized water. 
After stirring for 5 min, the suspension was dialyzed against 
deionized water for 24 h (2 x 1L) using a 3.5 kg/mol MWCO 
membrane to remove DMSO.  
Measurement of the critical aggregation concentration (CAC)  
A 1 mg/mL suspension of polymer assemblies was prepared as 
described above. 29 µL of a 0.1 mg/mL solution of Nile red in 
CH2Cl2 was added to each of a series of vials and then the 
solvent was evaporated to provide a thin film of Nile red. Next, 
13 serial dilutions of the polymer suspension ranging from 1 to 
2.5 x 10-4 mg/mL were added to the vials (1.5 mL/vial). The vials 
were then incubated at 37 °C overnight. Fluorescence emission 
spectra (520-700 nm) of each suspension were then measured 
using a QM-4 SE spectrometer from Photon Technology 
International (PTI) equipped with double excitation and 
emission monochromators. The excitation wavelength was 485 
nm and the emission intensity at lmax was record. The CAC was 
determined as the intercept of the two linear regions of the 
graph of fluorescence intensity vs. log(copolymer 
concentration).  
Particle degradation studied by DLS.  
Polymer assemblies were prepared as described above, except 
that the suspensions were dialyzed against 100 mM, pH 7.4 
phosphate buffer for 24 h (2 x 1 L) instead of deionized water. 
The resulting polymer concentration was ~ 1.0 mg/mL. The 
count rate was measured by DLS while fixing the attenuator at 
7. Then, the solution was divided in two. One half was kept in 
dark, while the other half was irradiated with UV light for 30 
min. The samples were then incubated at 37 °C in the dark and 
the DLS count rate was measured at selected time points. 
Loading of celecoxib.  
10 mg of block copolymer and 3 mg of celecoxib were dissolved 
in 0.5 mL of DMF and stirred for 4 h. The solution was then 
rapidly injected into 9.5 mL of stirring deionized water and the 
resulting suspension was stirred for an additional 1 min at speed 
of 700 rpm. The suspension was then dialyzed against 100 mM, 
pH 7.4 phosphate buffer (2 x 1L) for 16 h using a 3.5 kg/mol 
MWCO membrane. It was then filtered through glass pipette 
containing a cotton filter to remove any unencapsulated and 
precipitated drug. 100 μL of the resulting particle suspension 
was diluted into 1.6 mL of acetonitrile to fully dissolve the 
copolymer and celecoxib, then the solution was filtered through 
a 0.20 μm syringe filter (Acrodisc Syringe Filter Non-Pyrogenic 
13 mm, Pall Life Science) to remove any insoluble buffer salts. 
The absorbance at 250 nm was measured using a Varian UV/VIS 
Cary 300 spectrophotometer to calculate the celecoxib 
concentration (e = 22884 L/mol×cm). This experiment was 
performed in triplicate and was used to calculate the loading 
efficiency and drug content, where:  
Loading efficiency = (mass of loaded drug/mass of actual drug 
used) × 100%.  
Drug content = (mass of loaded drug/mass of nanoparticles with 
drug) × 100%.  
For analysis of the drug-loaded particles by TEM, the same 
procedure was used except that the particle suspension was 
dialyzed against deionized water instead of buffer. 
Triggered release of celecoxib.  
10 mL of drug-loaded polymer particle suspension (~1 mg/mL) 
was prepared as described above in pH 7.4 buffer, then was 
divided into two (5 mL) samples. One sample was irradiated for 
30 min, and the other was kept in dark. They were then 
incubated in the dark at 37 °C. At selected time points, ~0.2 mL 
of the suspension was removed and filtered through a glass 
pipette containing a cotton filter to remove the released and 
precipitated celecoxib. 100 µL of the filtered suspension was 
then diluted into 1.6 mL of acetonitrile and the resulting 
suspension was filtered through a 0.20 μm syringe filter 
(Acrodisc Syringe Filter Non-Pyrogenic 13 mm, Pall Life Science) 
to remove any insoluble buffer salts. The absorbance of the 
acetonitrile solution at 250 nm was measured to determine the 
percentage of drug remaining in the assemblies. Each time point 
was measured in triplicate to calculate standard deviations.  
In vitro cell toxicity assay.  
Polymer particles were prepared for the assay at a 
concentration of 10 mg/mL in deionized water using the 
procedure as described above, except at 10-fold higher polymer 
concentration. The suspension was then either irradiated with 
UV light for 30 min or not irradiated. It was diluted 10-fold with 
DMEM containing 10% FBS and 100 units/mL of Penstrep to 1 
mg/mL and then serial 2-fold dilutions were performed using 
the same medium. MDA-MB-231 cells were cultured in DMEM 
with 10% FBS and 100 units/mL of Penstrep in an atmosphere 
of 5% CO2 at 37 °C. The cells were seeded in a 96 well plate 
(Corning Flat Bottom Plate) at a density of 5,000 cells/well and 
allowed to adhere for 24 h. The medium was then aspirated and 
replaced with various concentrations of particles, 0.2-0.05 
mg/mL sodium dodecyl sulfate (positive control) or medium 
(negative control). The cells were incubated at 37 °C for 48 h. 
The medium was then aspirated and replaced with 100 µL of 
fresh medium containing 0.5 mg/mL (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) (MTT) reagent and the 
cells were incubated. After 4 h the plate was removed and the 
MTT reagent solution was aspirated. 50 µL of DMSO was added 
to each well to solubilize the formazan metabolic product of 
MTT. The plate was then placed in a plate reader (Tecan Infinite 
M1000 Pro) and the absorbance at 540 nm was measured to 
quantify the relative metabolic activities of the cells. 
Results and discussion 
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Polymer synthesis 
In addition to ethyl glyoxylate (EtG), three other aldehyde 
monomers were studied (Fig. 1). n-Butyl glyoxylate (BuG) is an 
analogue of ethyl glyoxylate, but with a longer aliphatic chain, 
making it more hydrophobic. L-Menthyl glyoxylate (MenG) is 
another hydrophobic analogue but is derived from a chiral and 
bioactive alcohol, making it of interest.44 Chloral (C) is not a 
glyoxylate, but has three chloro groups a to the aldehyde, 
making it susceptible to polymerization while at the same time 
being hydrophobic.45 EtG was purchased and purified as 
previously reported.40 C was purchased as its hydrate and then 
distilled over P2O5 to afford the aldehyde. BuG was synthesized 
as previously reported.34 MenG was synthesized via ozonolysis 
of its corresponding fumarate derivative (Scheme S1). 
Fig. 1. Chemical structures of the monomers used in the current work. 
Table 1. SEC and thermal analysis results for the polymers. aFrom SEC; bFrom TGA; cFrom 
DSC; dFrom previously published work. 
Polymers Mn (kg/mol)a Đa To (°C)b Tg (°C)c 
PEtGd 42 2.1 200 -5 
PEtBuG 30 2.1 226 -11 
PMenG 2.0 1.3 235 58 
PEtMenG 34 1.4 230 24 (Tm = 60) 
PEtGC 37 1.5 133 3 
 
Next, the polymerization of the monomers was investigated. 
The polymerization reactions were conducted at -20 °C with 
trace NEt3 and EtG hydrate as an initiator (Scheme 1, Table 1). 
After polymerization, the polymers were end-capped in situ 
with a UV light-responsive o-nitrobenzyl chloroformate 
derivative having an alkyne functional handle for subsequent 
conjugation of the PEG block.34 The resulting polymers were 
isolated by precipitation in methanol or dialysis against 1:1 
acetone:methanol. Poly(ethyl glyoxylate) (PEtG) was 
synthesized as previously reported.28 We have previously 
reported that homopolymerization of BuG gave low molar mass 
polymers, but that copolymerization with EtG afforded high 
molar masses with good incorporation of BuG.34 Here we 
copolymerized EtG and BuG in a 1.5:1 molar ratio (Scheme 1a). 
Based on 1H NMR spectroscopy, the resulting copolymer 
PEtBuG had a 1.9:1 mole ratio of the monomers, in reasonable 
agreement with the feed ratio. The number average molar mass 
(Mn) was 30 kg/mol and the dispersity (Đ) was 2.1 as measured 
by SEC in THF relative to PMMA standards. MenG was 
homopolymerized to afford PMenG with an Mn of 2.0 kg/mol 
and a Đ of 1.3 (Scheme 1b), but copolymerization of a 2:1 ratio 
of EtG:MenG provided the copolymer PEtMenG with an Mn of 
34 kg/mol, Đ of 1.4 and a 1.6:1 ratio of EtG:MenG (Scheme 1c). 
It is known that the homopolymerization of chloral leads to 
predominately an isotactic 4/1-helical structure in the 
crystalline state, and it is insoluble in all solvents.46 Therefore, 
we initially attempted the polymerization of a 1:1 ratio of EtG:C. 
The resulting copolymer precipitated from solution and could 
not be re-dissolved for analysis. Subsequently, we reduced the 
molar ratio to 3:1 EtG:C, but the resulting copolymer still had 
poor solubility in organic solvents such as CH2Cl2 and DMSO. 
Therefore, we polymerized a 5:1 ratio of EtG:C (Scheme 1d). The 
resulting copolymer PEtGC had an Mn of 37 kg/mol, Đ of 1.5, 
and a 19:1 ratio of EtG:C. The chloral content was much lower 
than that expected based on the monomer feed ratios, 
suggesting that the aldehyde of the C monomer was much less 
susceptible to polymerization than that of EtG, perhaps due to 
sterics associated with the three chlorine groups on the 
adjacent carbon.  
The thermal properties of the polymers were studied by TGA 
and DSC (Table 1, Figures S17-S22). Complete end-capping of 
the isolated polymers was confirmed by the fact that all of the 
polymers had onset degradation temperatures (To) higher than 
100 °C. We have previously observed that non-capped 
polyglyoxylates began depolymerizing below 100 °C.34 The To 
values for PEtG, PEtBuG, PEtMenG, and PMenG ranged from 
200 to 235 °C while PEtGC had a To of 133 °C. This suggests that 
the chloral component of the polymer substantially reduced the 
thermal stability. As all of the polymers had the same end-cap, 
this suggests that introduction of the trichloromethyl moiety 
introduces a thermally labile bond along the backbone that can 
initiate degradation upon cleavage. PEtG had a Tg of -5 °C, while 
PEtBuG had a Tg of -11 °C due to the introduction of flexible side 
chains. PMenG had a Tg of 57 °C, while PEtMenG had a Tg of 24 
°C. The increase in Tg for the menthyl-functionalized polymers 
can be attributed to the rigid cyclic structure of the menthyl 
moiety. PEtMenG also had a Tm of 60 °C. L-Menthol is a 
crystalline solid with a melting point of 41-44 °C, so crystallinity 
of the polymer likely arose from the menthyl moieties. It is 
possible that PMenG also had a Tm that was out of the range of 
the analysis (-60 – 150 °C, limited by the thermal stability of the 
polymers). PEtGC had a Tg of 3 °C, indicating that incorporation 
of the chloral moiety decreased segmental motion in the 
polymer, even at low monomer ratios. 
O O
O
ethyl glyoxylate (EtG)
O
Cl
Cl
Cl
chloral (C)
O O
O
n-butyl glyoxylate (BuG)
O
O
O
L-menthyl glyoxylate (MenG)
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Next, the polymers were converted to amphiphilic block 
copolymers by the conjugation of PEG to the alkyne moieties on 
the end-caps. PEG has been widely used as hydrophilic polymer 
for biomedical applications due to its high biocompatibility in 
various applications.47 The coupling reactions were conducted 
via copper-assisted akyne-azide cycloaddition reactions in DMF 
using azide-terminated PEG (PEG-N3) (Scheme 1). It should be 
noted that because the polymerization was initiated with the 
glyoxylate hydrate, there were end-caps on both termini and 
consequently the coupling resulted in the formation of triblock 
copolymers (PEG-polyglyoxylate-PEG). In order to study the 
influence of different hydrophilic mass fractions (f), PEtBuG and 
PEtGC were each coupled with 2 and 5 kg/mol PEGs to afford 
PEtBuG-PEG2000, PEtBuG-PEG5000, PEtGC-PEG2000 and 
PEtGC-PEG5000 (Table 2). PEtMenG was coupled with 2 kg/mol 
PEG to afford PEtMenG-PEG2000. Because of its short 
hydrophobic block length, PMenG was coupled with 750 g/mol 
PEG to afford PMenG-PEG750. In all cases, the excess of PEGs 
were removed by dialysis and water washes. The purified block 
copolymers were characterized by 1H NMR spectroscopy and 
SEC. Removal of uncoupled PEG was confirmed by SEC as no 
peaks corresponding to free PEG were observed (Figure S23-
S28) and the expected fractions of PEG were observed in NMR 
spectroscopy (Figure S11-S16). The f values ranged from 0.11 – 
0.39. 
 
Block copolymer self-assembly 
Self-assembly was performed via nanoprecipitation. 
Specifically, 0.1 mL of 10 mg/mL polymer solution in DMSO was 
injected into 0.9 mL of rapidly stirring water. After stirring for 5 
min, the assemblies were dialyzed against water to remove 
DMSO. The critical aggregation concentrations (CACs) of these 
assemblies were determined by encapsulation of Nile red. The 
CACs were all similar, ranging from 40 to 79 mg/L. However, as 
expected the assemblies with higher f values also had higher 
CACs (Table 2). In addition, for very similar f values of 0.10-0.11, 
the CACs were lower for the more hydrophobic polymers such 
as PEtBuG-PEG2000, PEtMenG-PEG2000, and PEtGC-PEG2000 
than for the previously reported PEtG-PEG2000. The maximum 
emission wavelength (lmax) of encapsulated Nile red can also 
serve as an indicator of the polarity of the environment at the 
core of the assembly, with a shift to shorter lmax indicative of a 
more less polar environment. At an assembly concentration of 
1 mg/mL, lmax ranged from 586 – 600 nm, with the assemblies 
having a lower CAC values, such as PEtMenG-PEG2000, PEtGC-
PEG2000, and PEtBuG-PEG2000, also having lower lmax. 
Overall, these results suggest that it was possible to tune the 
hydrophobicity of the assembly cores. 
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Scheme 1.  Synthesis of polymers a) PEtBuG; b) PMenG; c) PEtMenG; d) PEtGC and corresponding block copolymers via coupling of PEG-N3. 
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The assemblies were also characterized by dynamic light 
scattering (DLS) and transmission electron microscopy (TEM) 
(Figure 2, Figures S36-S42). Based on DLS, the hydrodynamic 
diameters ranged from 82 - 173 nm, with polydispersity indices 
(PDIs) of 0.12 - 0.37 (Table 2). Based on TEM (Figure 2 and Figure 
S42), all of these assemblies were solid-core particles with 
average diameters ranging from 37 – 157 nm. The diameters 
measured by TEM were generally smaller than those measured 
by DLS, which can result from differences between the hydrated 
and dried states, and possible aggregation of assemblies in the 
suspensions used for DLS measurements. While longer PEG 
chains and higher f values would be expected to more 
effectively stabilize the assemblies, TEM images showed that 
the particles with longer PEG blocks aggregated to form larger 
particles. This was reproducible across multiple experiments, 
and might be attributed to interactions of particle coronas 
during drying. As their appeared to be no significant advantages 
of having the longer PEG block based on TEM or DLS, further 
studies focused on the 2 kg/mol PEG copolymers.   
 
Fig. 2. TEM images of particles formed from (a) PEtBuG-PEG2000, (b) PEtBuG-
PEG5000, (c) PEtMenG-PEG2000, (d) PMenG-PEG750. (e) PEtGC-PEG2000, (f) 
PEtGC-PEG5000. 
 
Particle depolymerization 
Due to the presence of the UV light-responsive linker end-cap 
in each block copolymer, the hydrophobic blocks were expected 
to depolymerize upon irradiation with UV light, resulting in 
disassembly of the particles. In order to verify this, the particles 
were suspended in pH 7.4 phosphate buffer at a concentration 
of 1 mg/mL, then irradiated with 1.5 mW/cm2 of UVA light for 
Block copolymer Mnb (kg/mol) Đb f CAC (mg/L) Nile red 
lmax (nm)c 
Mean diameter 
from TEM (nm) 
Z-average diameter from DLS (nm) 
PEtG-PEG2000a 40 2.1 0.10 79 598 53 ± 17 82 ± 2 
PEtBuG-PEG2000 36 1.9 0.11 47 595 37 ± 11 105 ± 23 
PEtBuG-PEG5000 42 1.9 0.24 64 597 91 ± 107 110 ± 14 
PMenG-PEG750 5.9 1.2 0.39 64 600 39 ± 7 173 ± 17 
PEtMenG-PEG2000 35 1.5 0.11 52 586 38 ± 12 127 ± 26 
PEtGC-PEG2000 41 1.4 0.10 40 591 31 ± 16 139 ± 142 
PEtGC-PEG5000 36 1.3 0.28 62 594 157 ± 95 118 ± 21 
Table 2. Characterization data for the amphiphilic block copolymers and their resulting assemblies. aPreviously reported; bFrom SEC; cMeasured at 1 mg/mL of copolymer. 
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30 min. Controls consisted of non-irradiated particles. Particle 
disassembly was monitored based on the DLS count rate, which 
is proportional to particle number and particle mass when the 
attenuator is fixed at constant value. Thus, depolymerization 
would be expected to result in a decrease in the count rate. As  
shown in Fig. 3, without UV irradiation all of the particles were 
relatively stable in pH 7.4 at 37 °C for 24 h, with less than 20% 
reduction in count rate. However, after irradiation the particles 
disassembled almost immediately, leading to more than a 70% 
reduction in count rate over the first 2 h. Thus, the particles 
were indeed responsive to the light stimulus.  
 
Fig. 3. Depolymerization of particles following UV light irradiation (or no light for 
controls), monitored by DLS based on count rate. 
Celecoxib loading and release 
Celecoxib is anti-inflammatory drug that is used in the 
treatment of arthritis, and has also shown potential as a 
chemotherapeutic.48 However, it is limited by adverse side 
effects and low solubility (less than 3.3 mg/L), suggesting it 
could benefit from a drug delivery system. Therefore, celecoxib 
was loaded into the polymer assemblies. Drug loading was 
performed during the self-assembly process, with celecoxib co-
dissolved in the organic phase with the polymer prior to 
nanoprecipitation. In contrast to the assemblies without drug 
where DMSO performed best as the organic solvent, DMF was 
found to be the best solvent for preparing celecoxib-loaded 
assemblies with diameters less than 100 nm and high drug 
loading.  
As shown in Table 3, there were significant differences 
between the celecoxib content and loading efficiency for the 
different block copolymer assemblies. PEtBuG-PEG2000 and 
PEtMenG-PEG2000 assemblies had the highest celecoxib 
content at ~15 wt%, corresponding to a loading efficiency of 
~60%. This suggests that the incorporation of hydrophobic 
comonomers improved the loading of hydrophobic drugs, likely 
because the assembly cores became more hydrophobic. PEtGC-
PEG2000 assemblies had the lowest celecoxib loading of only 6 
wt%, corresponding to a loading efficiency of 21%. Although the 
cores of these assemblies were relatively hydrophobic based on 
the CAC values and the Nile red lmax, the chloride groups on the 
chloral monomer may not have good compatibility with 
celecoxib. PEtG-PEG2000 assemblies had an intermediate drug 
content of 10 wt% and a loading efficiency of 37%, which was 
significantly higher than PEtGC-PEG2000 and significantly lower 
than PEtBuG-PEG2000 and PEtMenG-PEG2000. To confirm that 
the f value didn’t have a significant influence on the drug 
content, celecoxib was also loaded into PEtBuG-PEG5000 
assemblies. The resulting celecoxib content was ~14 wt%, and 
not significantly different from that of PEtBuG-PEG2000. Thus, 
the chemical structure of the core block, rather than the block 
ratios dominates the loading efficiency.  
Table 3. Size characterization and celecoxib loading data for the block copolymer 
assemblies containing drug.  
 
 The drug-loaded assemblies were also characterized by TEM 
and DLS. TEM indicated that the PEtG-PEG-2000, PEtBuG-
PEG2000, and PEtMenG-PEG2000 assemblies remained as 
spherical particles after drug encapsulation (Figure S47). PEtGC-
PEG2000 assemblies were somewhere irregularly shaped, 
suggesting that the morphology was altered by celecoxib 
incorporation (Figure S47d). This may be related to the poor 
compatibility between celecoxib and the hydrophobic block, 
which was also reflected in the low drug loading content. The Z-
average diameters measured by DLS were all lower than those 
for the non-loaded assemblies and ranged from 51 – 97 nm.  
Next, the stimulus-mediated release of celecoxib from the 
particles was studied. Drug-loaded assemblies suspended in pH 
7.4 phosphate buffer were either stored in the dark to serve as 
controls or were irradiated for 30 min. Upon release from the 
assemblies, celecoxib precipitated due to its low aqueous 
solubility. At each time point, the precipitated drug was 
removed by filtration and the percentage of drug remaining 
suspended in the assemblies was measured.  
All of these particles released celecoxib much more rapidly 
following irradiation with UV light than without irradiation (Fig. 
4). PEtG-PEG2000 and PEtMenG-PEG2000 released more than 
70% of the celecoxib over the first 3 h. PEtBuG-PEG2000 and 
PEtGC-PEG2000 had more gradual release profiles, with ~40% 
and 50% respectively of the drug released over 3 h. The DLS 
Block 
copolymers 
Mean 
diameter 
from 
TEM 
(nm) 
Z-
average 
diameter 
from DLS 
(nm) 
PDI 
(from 
DLS) 
Drug 
loading 
content 
(%) 
Drug 
loading 
efficiency 
(%) 
PEtG-
PEG2000 
19 ± 8 63 ± 1 0.16 
± 
0.01 
10.0 ± 
2.6 
37.4 ± 
10.8 
PEtBuG-
PEG2000 
20 ± 10 51 ± 1 0.14 
± 
0.01 
15.0 ± 
3.2 
59.0 ± 
15.1 
PEtMenG-
PEG2000 
39 ± 12 52 ± 9 0.15 
± 
0.09 
15.1 ± 
5.2 
60.0 ± 
23.3 
PEtGC-
PEG2000 
34 ± 31 97 ± 2 0.16 
± 
0.01 
5.9 ± 
3.9 
21.2 ± 
15.1 
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results had indicated that all the particles disassembled very 
rapidly after irradiation. Therefore, the different apparent rates 
of drug release may be related to the drug crystallization 
process. For the cases where rapid celecoxib release was 
measured, it was observed that large celecoxib crystals were 
formed. This precipitate sedimented, resulting in a clear 
solution containing the PEG block and water-soluble small 
molecule depolymerization products. For the cases with 
apparent slow release of drug, the solution turbidity increased 
dramatically after irradiation, suggesting the formation of small 
celecoxib crystals that did not sediment. Based on the filtration 
process employed in our release assay, the larger drug crystals 
would have been filtered off more efficiently, whereas the 
smaller crystals would have remained, appearing as non-
released drug until they formed larger aggregates. It is known 
that the presence of small molecules in solution can influence 
the size of celecoxib crystals,49,50 so differences in 
depolymerization products may have influenced the 
crystallization and consequently the precipitation of the drug. 
To probe this further, we obtained IR spectra of mixtures of the 
polymer and celecoxib. In the case of PEtGC-PEG2000, we 
observed a shift in the C=O stretch of the aldehyde monomer in 
the presence of the drug, which is consistent with a drug-
monomer interaction (Fig. S49). However, for the other 
polymers, the ester C=O stretch dominated this region, so 
interactions could not be detected (Fig. S48, S50-S51). In any 
case, after 24 h, all of the triggered systems had released ~80% 
of the celecoxib. 
 
Fig. 4. Release of celecoxib over time for assemblies irradiated with UV light and 
for the corresponding systems stored in the dark. 
Non-triggered systems that were stored in the dark released 
celecoxib more slowly.  PEtBuG-PEG2000 most effectively 
retained the drug, with less than 5% released over 24 h. This 
suggests that the flexible hydrophobic butyl chains likely were 
not only favorable for obtaining high drug loadings, but also for 
retaining the drug in the absence of stimulus. Non-triggered 
PEtG-PEG2000 assemblies released ~20% of their celecoxib 
over 24 h, while PEtMenG-PEG2000 and PEtGC-PEG2000 
released ~45%. These rates were much slower than the 
analogous irradiated systems, but suggest that the chemical 
structure of the core-forming block has a significant influence 
on the retention of drug.  
 
In vitro toxicity studies 
The toxicity of each of the non-loaded assemblies was 
investigated using MDA-MB-231 human breast cancer cells. 
Each system was evaluated in its irradiated and non-irradiated 
form following a 48 h incubation with the cells. In the absence 
of irradiation, PEtMenG-PEG2000 and PMenG-PEG750 
assemblies showed minimal toxicity, with a high cell metabolic 
activity of >80% relative to control cells even at a concentration 
1 mg/mL (Fig. 5). Non-triggered PEtG-PEG2000, PEtBuG-
PEG2000, PEtBuG-PEG5000 assemblies had similar effects on 
cells, with 60% metabolic activity at a concentration of 1 
mg/mL. PEtGC-PEG2000 and PEtGC-PEG5000 assemblies 
showed higher toxicity with only ~30% metabolic activity 
remaining at 1 mg/mL.  
 
Fig. 5. Metabolic activities, measured by MTT assays of a) particles before UV 
irradiation and b) after UV irradiation.  
After irradiation, all the assemblies exhibited higher 
toxicities compared to the non-triggered particles. Irradiation-
induced depolymerization would produce the corresponding 
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glyoxylate and chloral monomers, which would be rapidly 
hydrated and hydrolyzed to glyoxylate or chloral hydrate and 
ethanol, n-butanol or L-menthol. Glyoxylate and ethanol can be 
metabolized in the liver but not in this cancer cell line.51,52 This 
may explain why some toxicity was observed in this assay (IC50 
~250 µg/mL), but not in whole organism studies previously 
reported.53 Like ethanol, n-butanol occurs in a number of 
alcoholic beverages and is considered have relatively low 
toxicity.54 It is also metabolized by alcohol dehydrogenase  in 
the liver. Chloral hydrate is used as a sedative for dental or 
medical treatments and has been administered to humans in 
gram-scale doses.55 However, it is metabolized to 
trichloroethanol and trichloroethanol glucuronide in red blood 
cells and in plasma,56 which would likely not happen in the 
current cell line and may explain why some toxicity to cells was 
observed. Interestingly, PEtMenG-PEG2000 and PMenG-
PEG750 assemblies, which were the least toxic in their non-
irradiated form were markedly more toxic than the other 
assemblies after irradiation, with an IC50 value on the order of 
50 µg/mL. Although L-menthol is generally considered safe and 
is widely used as a cooling agent in various products from cold 
medications to toothpaste, exposure to high doses can lead to 
toxic effects.57,58 Indeed the IC50 value we obtained for the 
triggered polymers is in reasonable agreement with those 
determined in previous in vitro toxicity assays of menthol (50 – 
120 µg/mL).59 This toxicity was attributed to menthol’s ability to 
cause the deterioration and induce leakage of mitochondrial 
membranes. Our assemblies therefore appear to be capable of 
depolymerizing and releasing biologically active menthol in 
response to stimuli. Given the interest in menthol as an 
analgesic, antifungal, antibacterial, and in other areas, the 
ability to release it in response to stimuli may prove useful for 
biomedical applications. Because of the complexities in the 
metabolic activity profiles of the different systems before and 
after irradiation, we chose to not evaluate the celecoxib-loaded 
particles in this assay.  
Conclusion 
In conclusion, we have successfully synthesized polyglyoxylates 
containing hydrophobic co-monomers including n-butyl 
glyoxylate, L-menthyl glyoxylate, and chloral. These polymers 
were end-capped with UV light-responsive linker, which 
allowed for their coupling with hydrophilic PEG to form 
amphiphilic block copolymers. The block copolymers were self-
assembled into particles with diameters ranging from 82 – 173 
nm in solution, and with cores having variable chemical 
structures and hydrophobicities, as indicated by measurements 
of their CAC values and the lmax of encapsulated Nile red dye. 
All of the particles had similar triggerable disassembly 
capabilities based on DLS. The drug loading content for the 
hydrophobic drug celecoxib ranged from 6 wt% for PEtGC-
PEG2000 to 15 wt% for of PEtBuG-PEG2000 and PEtMenG-
PEG2000, suggesting that some cores were more compatible 
with celecoxib than others. All systems released celecoxib more 
rapidly when triggered with UV light as a stimulus than when 
not triggered, but differences in the precipitation of the drug 
and in drug retention were observed for the different systems. 
Finally, in vitro toxicity studies were performed on MDA-MB-
231 cancer cells and it was found that the toxicity depended on 
the structure of the polymer and whether degradation had 
been triggered. Thus, it is possible to tune the self-assembly, 
drug loading, release, and toxicity of the polyglyoxylate 
assembly platform through simple tuning of the monomer 
polymer structures while retaining the essential stimuli-
responsive properties. Future work will focus on the loading and 
release of different hydrophobic drugs, and on further in vitro 
and in vivo studies aimed at optimizing these systems for drug 
delivery applications.  
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